   |
|
IJD SYMPOSIUM |
|
| Year : 2014 | Volume
: 59
| Issue : 5 | Page : 456-459 |
|
| Topical steroid-damaged skin |
|
|
Anil Abraham, Gillian Roga
Department of Dermatology, Venerology and Leprology, St. John's Medical College, Bangalore, Karnataka, India
| Date of Web Publication | 1-Sep-2014 |
Correspondence Address:
Anil Abraham
Department of Dermatology, Venerology and Leprology, St. John's Medical College, Bangalore 560 034, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.139872
|
|
 Abstract | | |
Topical steroids, commonly used for a wide range of skin disorders, are associated with side effects both systemic and cutaneous. This article aims at bringing awareness among practitioners, about the cutaneous side effects of easily available, over the counter, topical steroids. This makes it important for us as dermatologists to weigh the usefulness of topical steroids versus their side effects, and to make an informed decision regarding their use in each individual based on other factors such as age, site involved and type of skin disorder.
Keywords: Cutaneous, adverse, steroids
How to cite this article:
Abraham A, Roga G. Topical steroid-damaged skin. Indian J Dermatol 2014;59:456-9 |
What was known?
1. Topical corticosteroids, though very useful for treatment of dermatological disorders can produce various side effects.
2. Some of these side effects may seriously damage the skin.
3. Hence, topical corticosteroids should be used with utmost caution.
| Introduction | |  |
Topical steroids were introduced in 1951, when Sulzberger and Witten first used topical hydrocortisone. [1] The anti-inflammatory and anti-proliferative actions of topical steroids result not only in their therapeutic effect but also in their side effects [Table 1]. In this way steroids act as a double-edged sword, which makes it important to use it with the utmost caution.
| Adverse Effects of Topical Steroids on Skin | | |
Steroid Atrophy [Figure 1]
Physiology of skin atrophy due to topical steroids
Topical steroids cause the synthesis of lipocortin, which inhibits the enzyme phospholipase A2. Phospholipase A2 acts on the cell membrane phospholipids, to release arachidonic acid which causes the inflammation. The inhibition of phospholipase A2 results in the reduction of inflammation, mitotic activity and protein synthesis. [2] | Figure 1: Atrophy: Wrinkling and thinning of skin 4 weeks after irregular use of Mometasone
Click here to view |
Topical steroid use causes skin to go through three phases-preatrophy, atrophy and finally tachyphylaxis. Atrophy causes a burning sensation, and further steroid use causes vasoconstriction and soothing of the burning. When topical steroids are withdrawn, vasodilation occurs, till the vessels become more dilated than their initial diameter, and this is known as a "trampoline-like effect". This occurs due to the effect of steroids on nitric oxide in the endothelium. Release of endothelial nitric oxide stores results in "hyperdilation" of vessels. [3]
Pathogenesis of skin atrophy due to topical steroids
- Inhibitory effect on keratinocyte proliferation in the epidermis
- Inhibition of collagen 1 and 3 synthesis in the dermis
- Inhibition of fibroblasts and hyaluronan synthase 3 enzyme resulting in the reduction of hyaluronic acid in the extracellular matrix leading to dermal atrophy. [1],[4]
Factors that increase chances of atrophy are: Extremities of age, body site e.g. intertriginous areas, high-potency topical steroid, occlusion and moisture.
| Steroid-Induced Telangiectasia | | |
Steroid-induced telangiectasia occurs due to stimulation of release of nitric oxide from dermal vessel endothelial cells leading to abnormal dilatation of capillaries. [1]
| Steroid Acne | | |
The pathogenesis of topical steroid-induced acne has been proposed to be due to the degradation of the follicular epithelium, resulting in the extrusion of the follicular content. [1]
Factors predisposing to steroid acne are high concentration of the drug, application under occlusion, young adults below age 30, whites in preference to blacks and application to acne-prone areas of face and upper back.
| Steroid Rosacea | | |
Topical steroids increase the proliferation of Propionibacterium acnes, and Demodex folliculorum, leading to an acne rosacea-like condition within 6 months. It is also known as "iatrosacea", "topical steroid-induced rosacea-like dermatitis" (TCIRD) or "topical steroid-dependent face" (TSDF) [Figure 2]. [5] Mometasone furoate, known to be safe for use on the face, in reality is a medium-potency steroid, and has resulted in "mometasone-induced steroid rosacea". [6] Steroid-induced rosacea has been commonly associated with topical fluorinated steroids. [5] | Figure 2: Topical steroid - dependent face. Used as fairness cream for 2 months
Click here to view |
| Perioral Dermatitis | | |
Facial perioral dermatitis, more commonly seen in females, presents with follicular papules and pustules on an erythematous background, with sparing of the skin near the vermillion border of the lips. Steroid-induced perioral dermatitis is differentiated from common perioral dermatitis by history and clinical examination. Steroid-induced dermatitis has more erythema, inflammation, and scaling than its counterparts. Patients with steroid-induced dermatitis present with squeezed tubes of steroids that they have used and abused in hope of resolution of the skin condition. Hence, the term "tortured tube" sign. Substitution of hydrocortisone for fluorinated steroids resulted in the improvement of steroid-induced perioral dermatitis. [1],[7],[8]
| Purpura, Stellate Pseudoscars, Ulcerations | | |
Steroid-induced protein degradation leads to dermal atrophy and loss of intercellular substance, which further cause blood vessels to lose their surrounding dermal matrix, resulting in the fragility of dermal vessels, purpuric hypopigmented, and depressed scars. [1]
| Aggravation of Cutaneous Infections | | |
Tinea versicolor, onychomycosis, dermatophytosis and Tinea incognito [Figure 3] are the common cutaneous infections aggravated by topical steroids. Granuloma gluteale infantum is a persistent reddish purple, granulomatous, papulonodular eruption on the buttocks and thighs of infants. It occurs when diaper dermatitis is treated with topical steroids. [1]
| Delayed Wound Healing | | |
Delayed wound healing may occur due to various reasons. Inhibition of keratinocytes may cause epidermal atrophy and delayed re-epithelialization. Inhibition of fibroblasts-reduced collagen and ground substance may result in dermal atrophy and striae. Inhibition of vascular connective tissue may cause telangiectasia and purpura. Delayed granulation tissue formation may be caused by inhibition of angiogenesis. [1]
| Contact Sensitization to Topical Steroids | | |
Contact sensitization may occur due to prolonged use of steroids and application of certain drugs (e.g. nonfluorinated steroids - hydrocortisone, hydrocortisone 17-butyrate, budesonide). It is associated with cream formulations of steroids more often than ointments. Contact sensitization to topical steroids occurs due to the binding to amino acid arginine as part of certain proteins. Contact sensitization to steroids must be differentiated from hypersensitivity to other constituents e.g. lanolin, parabenes, antibiotics. [1]
Allergic contact dermatitis to topical steroids, presents as absence of response to treatment or as worsening of the dermatitis. It is usually seen in children with atopic dermatitis. Also, mild potent, steroids used commonly in children like desonide and hydrocortisone butyrate have an allergic property due to their structural instability. Some commonly used potent steroids are rare allergens, e.g. fluorinated corticosteroids, clobetasol propionate, betamethasone dipropionate, mometasone, etc. [9]
| Eyelid Dermatitis | | |
Patients with atopic and seborrheic dermatitis on chronic topical steroids, develop a flare around the eyes within 5-7 days after stoppage of steroids.
| Tachyphylaxis | | |
Topical corticosteroids may induce tachyphylaxis with chronic use. This is why the frequency of application of ultrahigh-potency topical corticosteroids is reduced after the first 2 weeks to no more than four or five times a week. Initially, steroids are effective; however, as time passes, patients stop responding to the same topical steroid and require oral steroids. Patients usually complain that steroids "are not effective anymore". [1]
| Trichostasis Spinulosa | | |
A study has shown the association of trichostasis spinulosa with topical steroids. It is characterized by dark-brown, follicular papules involving the face, neck, upper chest, arms, and antecubital areas with a rough sensation on palpation. On examination, tufts of hairs are visible projecting through each of the tiny papules. Treatment involves daily tretinoin 0.05% cream. [10]
| Striae (Rubrae Distensae) | | |
Striae due to steroids must be differentiated from those due to weight gain and pregnancy.
Pathogenesis of striae, according to Shuster, is due to the cross linking of immature collagen in the dermis, resulting in intradermal tears causing striae [Figure 4]. [11] Studies also show that deposition of collagen and scar tissue formation are implicated in the formation of striae. [1] | Figure 4: Striae due to topical steroid applied for 3 weeks for atopic dermatitis
Click here to view |
| Post Peel (Laser) Erythema Syndrome | | |
Persistent redness of the face, after peel or laser has been noted in patients using topical steroids before the procedure. [3]
| Status Cosmeticus | | |
Women with status cosmeticus cannot tolerate makeup and complain of a continuous burning sensation after any application. Patients present with erythema and burning disproportionate to the redness. Examination reveals atrophy, telangiectasia, and acneiform papules. With steroid withdrawal, the atrophy eventually clears. [3]
| Chronic Actinic Dermatitis-Like Eruption | | |
Patients present with facial erythema and lichenification on the face, forearms and upper neck. The difference between this condition and photo exacerbated dermatitis is that even though the rash is on the photo distributed area, it does not flare on sun exposure. [3]
| Corticosteroid Withdrawal Patterns | | |
The pattern of corticosteroid withdrawal is as follows: A week after corticosteroids are stopped, a mild erythema occurs at the site of the original dermatitis. This flare lasts for 2 weeks ending with desquamation. Dermatitis localized to the eyelids, face, scrotum, or perianal area often persists. A second flare usually occurs within 2 weeks. This pattern of flare and resolution repeats itself but each time smaller duration of flares and longer resolution periods. The length of the time for which steroids had been used initially determines the duration of the withdrawal phase. [3]
| Conclusion | | |
The key to safe use of topical steroid is short term use of appropriate potency steroid. However, when the skin condition remains resistant to treatment or affects a particular sensitive area, the prolonged use of steroids is not advisable. Selective glucocorticoid receptor agonists are being developed that have independent transrepression and transactivation action. This may lead to the development of a topical steroid without its adverse effects. [12]
| References | | |
| 1. | Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006;54:1-18. 
|
| 2. | Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: Clinical pharmacology and therapeutic use. Am J Clin Dermatol 2002;3:47-58.
|
| 3. | Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: The red burning skin syndrome. Clin Dermatol 2003;21:201-14.
|
| 4. | Schoepe S, Schäcke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006;15:406-20.
|
| 5. | Bhat YJ, Manzoor S, Qayoom S. Steroid-induced rosacea: A clinical study of 200 patients. Indian J Dermatol 2011;56:30-2.
[PUBMED]  |
| 6. | Fisher DA. Adverse effects of topical corticosteroid use. West J Med 1995;162:123-6.
[PUBMED] |
| 7. | Sneddon I. Perioral dermatitis. Br J Dermatol 1972;87:430-4.
[PUBMED] |
| 8. | Fowler KP, Elpern DJ. "Tortured tube" sign. West J Med 2001;174:383-4.
|
| 9. | Saraswat A. Topical corticosteroid use in children: Adverse effects and how to minimize them. Indian J Dermatol Venereol Leprol 2010;76:225-8.
[PUBMED] |
| 10. | Janjua SA, McKoy KC, Iftikhar N. Trichostasis spinulosa: Possible association with prolonged topical application of clobetasol propionate 0.05% cream. Int J Dermatol 2007;46:982-5.
|
| 11. | Shuster S. The cause of striae distensae. Acta Derm Venerol Suppl (Stockh) 1979;59:161-9.
|
| 12. | Khan MO, Lee HJ. Synthesis and pharmacology of anti-inflammatory steroidal antedrugs. Chem Rev 2008;108:5131-45.
|
What is new?
· The key to safe use of topical steroid is short term use of appropriate
potency steroid.
· Prolonged use of steroids is not advisable.
· Selective glucocorticoid receptor agonists are being developed that have
independent transrepression and transactivation action.
· This may lead to the development of a topical steroid without its adverse
effects.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1] |
|
| This article has been cited by | | 1 |
Evaluation of the effectiveness of oxytocin and enalapril in the prevention of epidural fibrosis developed after laminectomy in rats |
|
| Mustafa Ilker Karagedik, Ulas Yuksel, Bahar Kartal, Asli Fahriye Ceylan, Mustafa Ogden, Bulent Bakar | | Injury. 2023; | | [Pubmed] | [DOI] | | | 2 |
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study |
|
| Megan N Landis, Stacy R Smith, Gabriel Berstein, Gerald Fetterly, Pranab Ghosh, Gang Feng, Vivek Pradhan, Sudeepta Aggarwal, Christopher Banfield, Elena Peeva, Michael S Vincent, Jean S Beebe, Sanela Tarabar | | British Journal of Dermatology. 2023; | | [Pubmed] | [DOI] | | | 3 |
Two Cases of Adult Atopic Dermatitis Improved by Administration of Osuyu-tang |
|
| Ju-Hyun Lee, Sung-Gu Park, Eun-Heui Jo, Min-Cheol Park | | Journal of Korean Medicine. 2023; 44(1): 88 | | [Pubmed] | [DOI] | | | 4 |
Topical Steroid Damaged Face: A Cross-Sectional Study from Saudi Arabia |
|
| Mahdi Al Dhafiri, Alaa Baqer Alali, Zuhur Ali Alghanem, Zahraa Wasel Alsaleh, Eman Abdulrahman Boushel, Zahraa Baqer Alali, Aeshah Adel Alnajjar | | Clinics and Practice. 2022; 12(1): 140 | | [Pubmed] | [DOI] | | | 5 |
Evaluation of the Preliminary Safety, Tolerability and Colonisation Efficacy of Topical Probiotic Formulations Containing Micrococcus luteus Q24 in Healthy Human Adults |
|
| Rohit Jain, Abigail L. Voss, John R. Tagg, John D. F. Hale | | Cosmetics. 2022; 9(6): 121 | | [Pubmed] | [DOI] | | | 6 |
Effects of Indole-3-Lactic Acid, a Metabolite of Tryptophan, on IL-4 and IL-13-Induced Human Skin-Equivalent Atopic Dermatitis Models |
|
| Kyunghee Kim, Hyeju Kim, Gun Yong Sung | | International Journal of Molecular Sciences. 2022; 23(21): 13520 | | [Pubmed] | [DOI] | | | 7 |
Phytoecdysteroids from Serratula coronata L. for Psoriatic Skincare |
|
| Anna Kroma, Mariola Pawlaczyk, Agnieszka Feliczak-Guzik, Maria Urbanska, Dorota Jenerowicz, Agnieszka Seraszek-Jaros, Malgorzata Kikowska, Justyna Gornowicz-Porowska | | Molecules. 2022; 27(11): 3471 | | [Pubmed] | [DOI] | | | 8 |
English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021 |
|
| Hidehisa Saeki, Yukihiro Ohya, Junichi Furuta, Hirokazu Arakawa, Susumu Ichiyama, Toshio Katsunuma, Norito Katoh, Akio Tanaka, Yuichiro Tsunemi, Takeshi Nakahara, Mizuho Nagao, Masami Narita, Michihiro Hide, Takao Fujisawa, Masaki Futamura, Koji Masuda, Tomoyo Matsubara, Hiroyuki Murota, Kiwako Yamamoto-Hanada | | The Journal of Dermatology. 2022; | | [Pubmed] | [DOI] | | | 9 |
Platelet rich plasma in treatment of topical steroid damaged face: A retrospective analytical study |
|
| Imran Majid, Rosely Timungpi | | Dermatologic Therapy. 2022; | | [Pubmed] | [DOI] | | | 10 |
Anti-inflammatory effects of Eclipta prostrata Linné on house dust mite-induced atopic dermatitis in vivo and in vitro |
|
| Yun-Mi Kang, Hye-Min Kim, Hwan Lee, Dong-Sung Lee, Hyo-Jin An | | Journal of Ethnopharmacology. 2022; : 115233 | | [Pubmed] | [DOI] | | | 11 |
Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures |
|
| Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily B. Wong, Reena N. Rupani, Dario Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan, Alan Menter | | Journal of the American Academy of Dermatology. 2021; 84(2): 432 | | [Pubmed] | [DOI] | | | 12 |
Fractional Carbon Dioxide Laser Versus Carboxytherapy in Treatment of Striae Distensae |
|
| Eman H. Elmorsy, Yehia F. Elgarem, Eman S. Sallam, Alsayeda A. A. Taha | | Lasers in Surgery and Medicine. 2021; 53(9): 1173 | | [Pubmed] | [DOI] | | | 13 |
Topical corticosteroids for phimosis in children: a network meta-analysis of randomized clinical trials |
|
| Kannan Sridharan, Gowri Sivaramakrishnan | | Pediatric Surgery International. 2021; 37(8): 1117 | | [Pubmed] | [DOI] | | | 14 |
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study |
|
| Ulrich Mrowietz, A. David Burden, Andreas Pinter, Kristian Reich, Knut Schäkel, Patrick Baum, Yakov Datsenko, Hongjie Deng, Steven J. Padula, Christian Thoma, Robert Bissonnette | | Dermatology and Therapy. 2021; 11(2): 571 | | [Pubmed] | [DOI] | | | 15 |
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris |
|
| Katerina Svigos, Lu Yin, Lauren Fried, Kristen Lo Sicco, Jerry Shapiro | | American Journal of Clinical Dermatology. 2021; 22(5): 681 | | [Pubmed] | [DOI] | | | 16 |
IRE1 and PERK signaling regulates inflammatory responses in a murine model of contact hypersensitivity |
|
| Fabian Gendrisch, Lukas Völkel, Melanie Fluck, Petya Apostolova, Robert Zeiser, Thilo Jakob, Stefan F. Martin, Philipp R. Esser | | Allergy. 2021; | | [Pubmed] | [DOI] | | | 17 |
a-Linolenic acid attenuates pseudo-allergic reactions by inhibiting Lyn kinase activity |
|
| Yuanyuan Ding, Yuejin Wang, Chaomei Li, Yongjing Zhang, Shiling Hu, Jiapan Gao, Rui Liu, Hongli An | | Phytomedicine. 2021; 80: 153391 | | [Pubmed] | [DOI] | | | 18 |
Effects of Fractional CO2 Laser Treatment on Patients Affected by Vulvar Lichen Sclerosus: A Prospective Study |
|
| Maurizio Filippini, Jessica Sozzi, Miriam Farinelli, Alice Verdelli | | Photobiomodulation, Photomedicine, and Laser Surgery. 2021; 39(12): 782 | | [Pubmed] | [DOI] | | | 19 |
Recent Advances in the Synthesis of Ibuprofen and Naproxen |
|
| Min-Woo Ha, Seung-Mann Paek | | Molecules. 2021; 26(16): 4792 | | [Pubmed] | [DOI] | | | 20 |
Anti-Psoriatic Effects of Antimony Compounds In Vitro |
|
| Fabian Gendrisch, Birgit Haarhaus, Christoph M. Schempp, Ute Wölfle | | Molecules. 2021; 26(19): 5814 | | [Pubmed] | [DOI] | | | 21 |
Flavonoids in Skin Senescence Prevention and Treatment |
|
| Anna Domaszewska-Szostek, Monika Puzianowska-Kuznicka, Alina Kurylowicz | | International Journal of Molecular Sciences. 2021; 22(13): 6814 | | [Pubmed] | [DOI] | | | 22 |
Red Grape Polyphenol Oral Administration Improves Immune Response in Women Affected by Nickel-Mediated Allergic Contact Dermatitis |
|
| Thea Magrone, Emilio Jirillo, Manrico Magrone, Matteo A. Russo, Paolo Romita , Francesco Massari, Caterina Foti | | Endocrine, Metabolic & Immune Disorders - Drug Targets. 2021; 21(2): 374 | | [Pubmed] | [DOI] | | | 23 |
Glucocorticoid-Induced Skin Atrophy: The Old and the New |
|
| Elena Niculet, Carmen Bobeica, Alin L Tatu | | Clinical, Cosmetic and Investigational Dermatology. 2020; Volume 13: 1041 | | [Pubmed] | [DOI] | | | 24 |
Nanoencapsulation potentiates the cutaneous anti-inflammatory effect of p,p'-methoxyl-diphenyl diselenide: Design, permeation, and in vivo studies of a nanotechnological-based carrageenan gum hydrogel |
|
| Marcel Henrique Marcondes Sari, Bruna da Cruz Weber Fulco, Luana Mota Ferreira, Natháli Schopf Pegoraro, Evelyne da Silva Brum, Kamila Kayser Casola, Marila Crivellaro Lay Marchiori, Sara Marchesan de Oliveira, Cristina Wayne Nogueira, Letícia Cruz | | European Journal of Pharmaceutical Sciences. 2020; 153: 105500 | | [Pubmed] | [DOI] | | | 25 |
Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides |
|
| Hsin-Ju Li, Nan-Lin Wu, Chi-Ming Pu, Chien-Yu Hsiao, Der-Chen Chang, Chi-Feng Hung | | Scientific Reports. 2020; 10(1) | | [Pubmed] | [DOI] | | | 26 |
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019 |
|
| T. Luger, T. Dirschka, K. Eyerich, H. Gollnick, G. Gupta, J. Lambert, G. Micali, F. Ochsendorf, S. Ständer, C. Traidl-Hoffmann | | Journal of the European Academy of Dermatology and Venereology. 2020; 34(S7): 3 | | [Pubmed] | [DOI] | | | 27 |
Preclinical study of the topical anti-inflammatory activity of Cyperus rotundus L. extract (Cyperaceae) in models of skin inflammation |
|
| Fernanda Grillo Rocha, Margareth de Mello Brandenburg, Priscila Lúcia Pawloski, Bruna da Silva Soley, Simone Castagna Angelim Costa, Cristiane Claudia Meinerz, Irinéia Paulina Baretta, Michel Fleith Otuki, Daniela Almeida Cabrini | | Journal of Ethnopharmacology. 2020; 254: 112709 | | [Pubmed] | [DOI] | | | 28 |
Biopolymeric films as delivery vehicles for controlled release of hydrocortisone: Promising devices to treat chronic skin diseases |
|
| Guilherme T. Voss, Matheus S. Gularte, Renata L. de Oliveira, Cristiane Luchese, André R. Fajardo, Ethel A. Wilhelm | | Materials Science and Engineering: C. 2020; 114: 111074 | | [Pubmed] | [DOI] | | | 29 |
New and Emerging Therapies for Pediatric Atopic Dermatitis |
|
| Henry L. Nguyen, Katelyn R. Anderson, Megha M. Tollefson | | Pediatric Drugs. 2019; 21(4): 239 | | [Pubmed] | [DOI] | | | 30 |
A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors |
|
| Seema Patel, Abdur Rauf, Haroon Khan, Biswa Ranjan Meher, Syed Shams ul Hassan | | Biomedicine & Pharmacotherapy. 2017; 92: 501 | | [Pubmed] | [DOI] | | | 31 |
Dermoscopic Characteristics of Melasma in Indians: A Cross-sectional Study |
|
| Manas Chatterjee, Shekhar Neema | | International Journal of Dermoscopy. 2017; 1(1): 6 | | [Pubmed] | [DOI] | | | 32 |
Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase |
|
| Xiaoming Fan, Qiuhong Duan, Changshu Ke, Guiping Zhang, Juanjuan Xiao, Dan Wu, Xiaoyu Zeng, Jingwen Chen, Jinguang Guo, Jie Zhou, Fei Shi, Feng Zhu | | Oncotarget. 2016; 7(17): 24633 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
